Risk of infection lower with SGLT2i than DPP4i

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2017卷 / 1期
关键词：
D O I：
10.1007/s40278-024-62986-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [41] Risk of genitourinary infection similar among SGLT2i in patients with heart failure and preserved ejection fraction
    Reactions Weekly, 2024, 2011 (1) : 10 - 10
  • [42] Hypertension approaches and recent SGLT2i studies
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2024, 16 (11)
  • [43] SGLT2I AS RENOPROTECTION TOOL IN CHILDREN WITH CKD
    Ivanov, Dmytro
    Ivanova, Mariia
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3325 - 3325
  • [44] Will the SGLT2i Responders Please Stand Up?
    Banner, Kane
    Silverman, Daniel N.
    CIRCULATION-HEART FAILURE, 2023, 16 (11)
  • [45] The Risk of Heart Failure Hospitalization after Initiation of SGLT2i, GLP-1RA, DPP-4i, or SUs in Patients with Type 2 Diabetes and Low-to-Moderate CV Risk
    Tesfaye, Helen
    Paik, Julie M.
    Alix, Caroline
    Cromer, Sara Jane
    Everett, Brendan M.
    Glynn, Robert
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2024, 73
  • [46] Mineral and Electrolyte Disorders With SGLT2i Therapy
    Cianciolo, Giuseppe
    De Pascalis, Antonio
    Capelli, Irene
    Gasperoni, Lorenzo
    Di Lullo, Luca
    Bellasi, Antonio
    La Manna, Gaetano
    JBMR PLUS, 2019, 3 (11)
  • [47] Potential adverse effects of SGLT2i in horses
    McGorum, Bruce C.
    Keen, John A.
    McCullagh, Sophie
    Marr, Celia M.
    MacKenzie, Catriona
    Carslake, Harry
    Menzies-Gow, Nicola
    Dunkel, Bettina
    Hewetson, Mike
    Reed, Jennifer
    Knowles, Edd
    VETERINARY RECORD, 2024, 195 (06) : 253 - 254
  • [48] The Risk of Major CV Events after Initiation of SGLT2i, GLP-1RA, DPP-4i, or SUs in Patients with Type 2 Diabetes and Low-toModerate CV Risk
    Patorno, Elisabetta
    Tesfaye, Helen
    Alix, Caroline
    Dicesare, Elyse C.
    Cromer, Sara Jane
    Everett, Brendan M.
    Glynn, Robert
    Wexler, Deborah J.
    Paik, Julie M.
    DIABETES, 2024, 73
  • [49] SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY
    Suzuki, Shigeru
    Kokumai, Takahide
    Furuya, Akiko
    Takahashi, Satoru
    DIABETES CARE, 2023, 46 (03) : E74 - E75
  • [50] DPP4i and GLP1RA increase risk of gallbladder and bile duct disorders
    Reactions Weekly, 2025, 2050 (1) : 8 - 8
12345